CLINICAL_TRIALS
trial_result
· 2015-06-02
Clinical Trial Update: Niacin Skin Flush Response in Patients With Schizophrenia [Phase 2, Phase 3]
Summary
Completion of a Phase 2/Phase 3 trial evaluating the niacin skin flush response in schizophrenia patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Isfahan University of Medical Sciences | Conditions: Schizophrenia | Phase 2, Phase 3 | Status: COMPLETED